Advertisement

Index by author

May 01, 2016; Volume 89,Issue 5

A

  1. Alvarez-Curto, Elisa

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

  2. Andonian, Clara

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  3. Arnold, Samuel L.M.

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

B

  1. Bauer, Carsten

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  2. Bradley, Michelle E.

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  3. Buhl, Derek L.

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  4. Butcher, Adrian J.

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

C

  1. Chanda, Pranab K.

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  2. Chapman, John D

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

  3. Charlton, Steven J.

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  4. Chasseigneaux, Stephanie

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  5. Chen, Liangfu

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  6. Chu, Xiaoyan

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  7. Cohen, Jonathan B.

    1. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator
      Ayman K. Hamouda, Farah Deba, Ze-Jun Wang and Jonathan B. Cohen
      Molecular Pharmacology May 2016, 89 (5) 575-584; DOI: https://doi.org/10.1124/mol.116.103341

D

  1. Dallas, Shannon

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  2. Deba, Farah

    1. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator
      Ayman K. Hamouda, Farah Deba, Ze-Jun Wang and Jonathan B. Cohen
      Molecular Pharmacology May 2016, 89 (5) 575-584; DOI: https://doi.org/10.1124/mol.116.103341

  3. Declèves, Xavier

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  4. Dell’Acqua, Mark L.

    1. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
      Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
      Molecular Pharmacology May 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085

  5. DiLoreto, Karen

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  6. Dror, Ron O.

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  7. Dubois, Gerald

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

F

  1. Freund, Ronald K.

    1. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
      Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
      Molecular Pharmacology May 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085

G

  1. Gibson, Emily S.

    1. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
      Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
      Molecular Pharmacology May 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085

  2. Gibson, Stacy

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  3. Gomez-Zepeda, David

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  4. Goodlett, David R

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

  5. Green, Michael

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  6. Guo, Dong

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

H

  1. Hamouda, Ayman K.

    1. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator
      Ayman K. Hamouda, Farah Deba, Ze-Jun Wang and Jonathan B. Cohen
      Molecular Pharmacology May 2016, 89 (5) 575-584; DOI: https://doi.org/10.1124/mol.116.103341

  2. Han, Chang Y

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

  3. Hansen, Kristina K.

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  4. Heitman, Laura H.

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  5. Hoft, Carolin

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  6. Hogarth, Cathryn A

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

  7. Hollenberg, Morley D.

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  8. Huang, Michael L.H.

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  9. Hudson, Brian D.

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

I

  1. IJzerman, Adriaan P.

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  2. Insel, Paul A.

    1. The Molecular Pharmacology of G Protein Signaling Then and Now: A Tribute to Alfred G. Gilman
      Roger K. Sunahara and Paul A. Insel
      Molecular Pharmacology May 2016, 89 (5) 585-592; DOI: https://doi.org/10.1124/mol.116.104216

  3. Isoherranen, Nina

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

K

  1. Kent, Travis

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

  2. Knafels, John D.

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  3. Kovacevic, Zaklina

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  4. Kunta, Jeevan

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

L

  1. Langer, Oliver

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  2. Laplanche, Loic

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  3. Liu, Rongfang

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  4. Lu, Jiaoyang

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

M

  1. Menet, Marie-Claude

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  2. Menezes, Sharleen

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  3. Mezler, Mario

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  4. Miah, Asadh

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  5. Mihara, Koichiro

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  6. Miller, Ashley M.

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

  7. Milligan, Graeme

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

  8. Mocking, Tamara

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  9. Mony, Laetitia

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

O

  1. Onken, Jennifer

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

P

  1. Pan, Albert C.

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  2. Pandit, Jayvardhan

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  3. Pang, Jodie

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  4. Paoletti, Pierre

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  5. Park, Kyung Chan

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  6. Pereira, Tony

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  7. Pierre, Esaie

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  8. Polley, Danny

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  9. Potter, Huntington

    1. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
      Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
      Molecular Pharmacology May 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085

  10. Prihandoko, Rudi

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

R

  1. Ramachandran, Rithwik

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  2. Reilly, John

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  3. Renaux, Bernard

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  4. Richardson, Des R.

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  5. Riddy, Darren M.

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  6. Rode, Anja

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

S

  1. Sahni, Sumit

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  2. Saifeddine, Mahmoud

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

  3. Salphati, Laurent

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  4. Sandham, David A.

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  5. Scheer, Nico

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  6. Sciabola, Simone

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  7. Shaw, David E.

    1. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
      Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
      Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657

  8. Simic, Damir

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  9. Stroebel, David

    1. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      Open Access
      A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
      David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
      Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036

  10. Sunahara, Roger K.

    1. The Molecular Pharmacology of G Protein Signaling Then and Now: A Tribute to Alfred G. Gilman
      Roger K. Sunahara and Paul A. Insel
      Molecular Pharmacology May 2016, 89 (5) 585-592; DOI: https://doi.org/10.1124/mol.116.104216

  11. Sykes, David A.

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

T

  1. Tobin, Andrew B.

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

  2. Tripathy, Sasmita

    1. RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
      Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
      Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697

U

  1. Ulven, Trond

    1. Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
      Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
      Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949

V

  1. Vanderboor, Christina

    1. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
      Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
      Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

W

  1. Wanek, Thomas

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  2. Wang, Ze-Jun

    1. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator
      Ayman K. Hamouda, Farah Deba, Ze-Jun Wang and Jonathan B. Cohen
      Molecular Pharmacology May 2016, 89 (5) 575-584; DOI: https://doi.org/10.1124/mol.116.103341

  3. Wangpu, Xiongzhi

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

  4. Watson, Simon J.

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

  5. Willard, Elizabeth

    1. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
      David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
      Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832

X

  1. Xi, Ruxing

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

Y

  1. Yabut, Jocelyn

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  2. Yue, Fei

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044

Z

  1. Zhang, Xiaolin

    1. Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
      Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
      Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079

  2. Zheng, Minhua

    1. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
      Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044
Back to top

In this issue

Advertisement